Innoviva, Inc.
INVA US45781M1018
Innoviva Inc is a company with a portfolio of royalties healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others.
Annual Insiders Turnover, USD 2
1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);
Insider Activity
Person | Price | Shares | Total | Published | Completed |
---|---|---|---|---|---|
Zhen Marianne CCO |
13.97 USD |
5,405 Sold |
75,508 USD |
15/11/2023 | 15/11/2023 |
Zhen Marianne CCO |
14.01 USD |
5,589 Sold |
78,302 USD |
15/11/2023 | 15/11/2023 |